Data as of .
BIOY vs SEMY: which paid, and which earned it?
BIOY and SEMY both write options for income.
What they hold in common
By the books each fund has filed, BIOY and SEMY hold 51% of their money in the same securities at the same weight.
| Holding | BIOY | SEMY |
|---|---|---|
| Treasury Bill | 100.00% | 50.64% |
| Only in BIOY | Only in SEMY |
|---|---|
| Treasury Bill 49.36% |
Weight overlap is an ETFIQ calculation: for every security both funds hold, the smaller of the two weights, summed. Above 50%, holding both is close to holding one of them twice. Holdings dated Jun 30, 2026.
Performance, window by window
| Window | Total return | Cash paid | Against the benchmark | |||
|---|---|---|---|---|---|---|
| BIOY | SEMY | BIOY | SEMY | BIOY | SEMY | |
| 3 months | +2.5% | −4.8% | 14.1% | 17.4% | −9.0 pts | +8.4 pts |
| 6 months | not published | +17.5% | not published | 43.7% | not published | −31.4 pts |
| Since launch | +2.0% | +33.9% | 20.6% | 71.5% | −15.3 pts | −38.5 pts |
| BIOY GraniteShares YieldBOOST Biotech ETF Synthetic covered call on XBI, paying weekly | SEMY GraniteShares YieldBOOST Semiconductor ETF Synthetic covered call on SMH, paying weekly | |
|---|---|---|
| Issuer | GraniteShares | GraniteShares |
| Strategy | synthetic covered call | synthetic covered call |
| Benchmark | Biotech (XBI), used as the proxy | Semiconductors (SMH) |
| Pays | weekly | weekly |
| Payout rate, annualized | 60.0% | 67.3% |
| Expense ratio | 1.07% | 1.07% |
| Cash paid, 1 year | 20.6% (since launch on May 5, 2026) | 71.5% (since launch on Nov 18, 2025) |
| Price change, 1 year | −19.0% | −48.7% |
| Total return, 1 year | +2.0% (since launch on May 5, 2026) | +33.9% (since launch on Nov 18, 2025) |
| Benchmark return, 1 year | +17.3% | +72.5% |
| Ahead or behind | −15.3 pts | −38.5 pts |
| Return of capital, latest estimate | 96% | 98% |
| Age | 136 days | 304 days |
| Net assets | $1m | $49m |
BIOY in plain words
Over the period since launch on May 5, 2026 to Sep 18, 2026, BIOY paid 20.6% of its starting value in cash distributions while its price fell 19.0%. With every distribution reinvested, the fund returned +2.0%. Biotech (XBI), used as the proxy returned +17.3% over the same days, so a holder was behind by 15.3 pts. At its price on Sep 18, 2026 the latest distribution annualizes to 60.0%, paid weekly. GraniteShares estimates that 96% of the distribution paid Aug 25, 2026 was a return of capital (19a-1 notice, estimated, a tax characterization rather than a measure of erosion).
SEMY in plain words
Over the period since launch on Nov 18, 2025 to Sep 18, 2026, SEMY paid 71.5% of its starting value in cash distributions while its price fell 48.7%. With every distribution reinvested, the fund returned +33.9%. Semiconductors (SMH) returned +72.5% over the same days, so a holder was behind by 38.5 pts. At its price on Sep 18, 2026 the latest distribution annualizes to 67.3%, paid weekly. GraniteShares estimates that 98% of the distribution paid Aug 25, 2026 was a return of capital (19a-1 notice, estimated, a tax characterization rather than a measure of erosion).
Questions people ask
- Which is cheaper, BIOY or SEMY?
- BIOY charges 1.07% a year and SEMY charges 1.07%, so BIOY is cheaper. Fees come from each fund's prospectus.
Other comparisons
Where these figures came from
ETFIQ links to the documents behind every figure. It is not affiliated with any issuer, and a link is not an endorsement.
Cite this page. ETFIQ, BIOY against SEMY, data as of Sep 18, 2026. https://etfiq.com/compare/income/bioy-vs-semy Free to use with attribution; the underlying files are at Open data.